BioMarin Deutschland
This company is committed to the communities it treats beyond the therapies.
Launch date
Employees
Market cap
AUD24.8b
Enterprise valuation
AUD24.6b (Public information from Sep 2024)
Share price
$71.41 BMRN
Company register number HRB 95536 (Frankfurt am Main)
San Rafael California (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.7b | 1.9b | 1.8b | 2.1b | 2.4b | 2.8b | 3.1b |
| % growth | 14 % | 9 % | (1 %) | 14 % | 15 % | 16 % | 11 % |
| EBITDA | (22.2m) | (5.8m) | 48.0m | 160m | 310m | - | - |
| % EBITDA margin | (1 %) | - | 3 % | 8 % | 13 % | - | - |
| Profit | (23.8m) | 859m | (64.1m) | 142m | 168m | - | - |
| % profit margin | (1 %) | 46 % | (3 %) | 7 % | 7 % | - | - |
| R&D budget | 715m | 628m | 629m | 650m | 747m | - | - |
| R&D % of revenue | 42 % | 34 % | 34 % | 31 % | 31 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
* | N/A | $586m | Post IPO Convertible |
* | $1.0b | Post IPO Equity | |
| Total Funding | - | ||
Related Content
Recent News about BioMarin Deutschland
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.